Table 5.
Outcome of participants in (STV and PLC) group after 3 months (1st follow up) of treatment period.
| Different Variables | Group 2- PLC |
Group 1- STV |
||||
|---|---|---|---|---|---|---|
| Baseline Data, Mean (±SD) |
1st follow up Data, Mean (±SD) |
p value | Baseline Data, Mean (±SD) |
1st follow up Data, Mean (±SD) |
p value | |
| Weight | 66.53(±10.94) | 66.17(±10.48) | .295 | 68.82 (±8.23) | 68.94 (±8.97) | .916 |
| BMI | 25.79(±3.16) | 25.64 (±2.90) | .276 | 26.34 (±3.46) | 26.18 (±3.64) | .758 |
| SBP | 133.46 (±16.98) | 122.05 (±14.17) | .000*** | 133.86 (±21.37) | 126.14 (±14.01) | .042* |
| DBP | 82.56 (±7.85) | 78.33 (±10.65) | .010** | 84.77 (±12.66) | 79.32 (±5.45) | .008*** |
| FBS | 6.34 (±1.43) | 7.04 (±2.55) | .092 | 6.94 (±2.26) | 6.19 (±1.49) | .041* |
| PBS | 9.45 (±4.89) | 10.14 (±4.62) | .412 | 9.58 (±3.71) | 8.11 (±2.03) | .013* |
| Blood urea | 5.47 (±4.06) | 5.30 (±1.46) | 0.794 | 8.30 (±8.21) | 5.84 (±4.47) | .092 |
| S creatinine | 104.52 (±29.87) | 110.19 (±31.02) | 0.182 | 87.22 (±42.58) | 101.80 (±24.10) | .027* |
| STP | 74.41 (±5.64) | 74.10 (±4.90) | .783 | 71.84 (±11.75) | 72.09 (±10.80) | .891 |
| S Uric acid | 312.28 (±107.86) | 349.1(±105.52) | .002** | 361.98 (±134.66) | 303.02 (±112.38) | .009*** |
| Ca | 2.23 (±.16) | 2.19 (±.13) | .118 | 3.20 (±4.08) | 2.18 (±.14) | .104 |
| In phos. | 1.10 (±.21) | 1.11 (±.20) | .635 | 1.28 (±.67) | 1.17 (±.20) | .26 |
| Na | 138.77 (±2.46) | 140.18 (±2.59) | .010* | 138.57 (±3.04) | 139.27 (±2.39) | .215 |
| K | 4.18 (±.50) | 4.10 (±.55) | 0.286 | 3.92 (±.51) | 3.99 (±.49) | .419 |
| Cl | 103.28 (±3.30) | 105.28 (±2.82) | .001** | 102.59 (±4.27) | 103.50 (±3.26) | .173 |
| TCO2 | 26.73 (±1.81) | 26.79 (±2.41) | .879 | 27.41 (±1.89) | 27.18 (±2.24) | .490 |
| M albumin | 198.38 (±267.30) | 168.5(±256.16) | .279 | 133.26 (±261.74) | 56.20 (±80.91) | .041* |
| UTP(SPOT) | 59.82 (±79.07) | 56.20 (±81.60) | .767 | 49.14 (±79.81) | 71.13 (±124.92) | .283 |
| ACR | 240.9 (±366) | 160.8 (±270.93) | .027* | 187.34 (±412.05) | 187.64 (±343.68) | .997 |
| PCR | .72(±.89) | .50(±.66) | .011* | .650 (±.92) | 10.73 (±62.92) | .294 |
| e GFR | 62.85 (±18.16) | 62.92 (±20.57) | .964 | 65.45 (±21.93) | 65.84 (±21.82) | .918 |
Values are presented as Mean (±SD), where, (*p < 0.05) = significant, (**p < 0.01) = highly significant, (***p < 0.001) = very highly significant as compared to the baseline and 1st follow up data of different study groups. Data were analyzed by Paired Sample T-test. Here, BMI= Body mass index, SBP= Systolic blood pressure, DBP = Diastolic blood pressure, FBS= Fasting blood sugar, PBS= Postprandial blood sugar, In. phos. = Inorganic phosphate, S. creatinine = Serum creatinine, M. albumin = Microalbumin, STP= Serum total protein, S. uric acid = Serum uric Acid, TCO2 = Total CO2, UTP= Urinary total protein, ACR = Albumin: Creatinine; PCR= Protein: Creatinine; eGFR = estimated glomerular filtration rate.